Endothelial dysfunction in rheumatic autoimmune diseases
- 1 October 2012
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 224 (2), 309-317
- https://doi.org/10.1016/j.atherosclerosis.2012.05.013
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in miceJCI Insight, 2011
- Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissuesFibrogenesis & Tissue Repair, 2011
- Tregs and Human Atherothrombotic DiseasesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosisThe Journal of Experimental Medicine, 2010
- Dendritic cells in atherosclerotic diseaseClinical Immunology, 2010
- The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesisJournal of Biomedical Science, 2009
- Macrophage death and defective inflammation resolution in atherosclerosisNature Reviews Immunology, 2009
- Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophilsEuropean Journal of Immunology, 2009
- Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of AtherosclerosisArthritis Research & Therapy, 2009
- Subclinical Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus ErythematosusThe American Journal of Medicine, 2008